CAMKK2 and posterior cortical atrophy: Massie et al. integrated genome-wide AR-binding transcript profiling with an analysis of androgen-stimulated recruitment of the transcriptional machinery to a core set of AR-binding sites and identified CaMKK2 to be consistently enriched in PCa clinical cohorts, in a pattern similar to that of the established PCa marker AMACR (86).